ADAR1 Capital Management »

Krystal Biotech shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Krystal Biotech (KRYS) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Krystal Biotech

Tip: Access up to 7 years of quarterly data

All positions including Krystal Biotech held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Krystal Biotech by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $53k 300 177.93

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Krystal Biotech

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Frazier Life Sciences Management
Capital World Investors
Redmile Group
Dimensional Fund Advisors
Geode Capital Management
Susquehanna International
T. Rowe Price Associates
Goldman Sachs Group
Jennison Associates
Invesco
Nuveen Asset Management

View all funds holding Krystal Biotech